not hungry at all on tirzepatide Why Am I Still Tirzepatide? Causes and Solutions what to eat on tirzepatide

Autophagy in Atherosclerosis A Potential Drug Target for Plaque Stabilization

The information provided here is NOT MEDICAL ADVICE and is for informational and educational purposes only

Tirzepatide is the first dual GIP and GLP-1 receptor agonist approved for clinical use, combining two incretin pathways that were previously only targeted individually

2 Introduction/background: history of incretin mimetics medications GIP was the first incretin isolated and characterized in the 1970s though most modern therapies focus on GLP-1 [17]

If you have sudden or irregular pigmentation, or if your pigmentation is persistent, then you should seek the care of a specialist